Skip to main content
Caplight Logo









HAS Healthcare Advanced Synthesis SA

HAS Healthcare Advanced Synthesis SA

Private
BiascaHealthcare & Life Scienceshttps://www.hashealthcare.com/

Last Round

Private Equity

Mar 31, 2025

Est. Valuation

$380M

Total Funding Raised

$152M

Company Overview

HAS Healthcare Advanced Synthesis SA is a pharmaceutical company that develops and manufactures active pharmaceutical ingredients (APIs), highly potent APIs (HPAPIs), and anticancer compounds for the pharmaceutical and biotechnology industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain, Precision Medicine, Compliance

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOactive pharmaceutical ingredientsAPIhighly potent active pharmaceutical ingredientsHPAPIoncology drug manufacturingcGMP manufacturingchemical synthesispharmaceutical outsourcingmicronizationdrug substance productionanalytical servicespharma supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HAS Healthcare Advanced Synthesis SA Comparables

Compare HAS Healthcare Advanced Synthesis SA with similar companies based on industry and business-model similarity.

HAS Healthcare Advanced Synthesis SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axplora
87%
Sterling Pharma Solutions
86%
CordenPharma
83%

HAS Healthcare Advanced Synthesis SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMar 31, 2025

HAS Healthcare Advanced Synthesis SA Investors

Notable investors and investment history

HAS Healthcare Advanced Synthesis SA investors
InvestorRounds
65 Equity PartnersPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors increased 44% MoM.

  • Apr 4, 2026

    Monthly visitors increased 133% MoM.

HAS Healthcare Advanced Synthesis SA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HAS Healthcare Advanced Synthesis SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HAS Healthcare Advanced Synthesis SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersBiasca
Employee Range107
Year Founded1984
Last FundingMar 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?